There was a lot to cheer outside Enterprise Center Tuesday morning. Riders ready to brave their bikes with the St. Louis ...

TENS of thousands of Brits are estimated to be unknowingly living with the silent heart condition that nearly killed ...

An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...

Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...

"If patients with low or no PD-L1 expression are not expected to benefit based on the available data, then administering anti ...

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) shares are trading lower by 4.11% to $15.62 during Tuesday’s session after the ...

Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

The "Thyroid Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest analytical report reveals a dynamic environment in the developmental landscape of ...

After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, taking up the top science spot at Sanofi.

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Several studies revealed high cardiovascular risk in people with type 1 diabetes, including in those who are asymptomatic and ...

Delayed diagnosis and treatment of CCCA result in insufficiently aggressive therapy and risks an avoidable consequence, ...